During the past decade, New Mexico Oncology Hematology Consultants conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 33 clinical trials were completed, i.e. on average, 57.9% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 22 clinical trials were completed. i.e. 169.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Mexico Oncology Hematology Consultants" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "NRG Oncology" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored and "CTI BioPharma" with 5 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Mexico Oncology Hematology Consultants" #1 collaborator was "National Cancer Institute (NCI)" with 40 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "New Mexico Oncology Hematology Consultants" are "Breast Cancer" (10 trials), "Prostate Cancer" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "New Mexico Oncology Hematology Consultants" in a lesser frequency.

Most popular intervention types in "New Mexico Oncology Hematology Consultants" are "Drug" (85 trials), "Other" (34 trials), "Biological" (33 trials), "Radiation" (23 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Nivolumab" (12 trials), "Quality-of-Life Assessment" (12 trials), "Computed Tomography" (10 trials) and "Biospecimen Collection" (9 trials). Other intervention names were less common.

The vast majority of trials in "New Mexico Oncology Hematology Consultants" are 80 trials for "All" genders, 14 trials for "Male" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "New Mexico Oncology Hematology Consultants". undefined are not yet recruiting, 15 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in New Mexico Oncology Hematology Consultants, 2 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in New Mexico Oncology Hematology Consultants, 2 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".